Adipose tissue lipogenesis is paradoxically impaired in human obesity, promoting ectopic triglyceride (TG) deposition, lipotoxicity, and insulin resistance. We previously identified 
INTRODUCTION
Extreme human obesity triggers adipose dysfunction, paradoxically resulting in decreased capacity for lipid synthesis and contributing to ectopic lipid deposition, lipotoxicity, and whole body insulin resistance (1) . Lipodystrophic human subjects and mouse models demonstrate that deficits in adipose lipogenesis correlate with excess lipid deposition in liver and muscle as well as whole body insulin resistance, highlighting the importance of adipose lipogenesis in metabolic dysfunction (1) (2) (3) (4) . Adipose tissue expression and activity of the lipogenic transcription factors peroxisome proliferator activated receptor gamma (PPARγ), sterol-regulated element binding protein-1 (Srebp-1), and carbohydrate responsive element-binding protein (Chrebp, also known as Mlxipl) are suppressed in obese humans, leading to decreased expression of lipogenic enzymes and decreased adipose fatty acid (FA) and triglyceride (TG) synthesis; however, the mechanisms that lead to this inhibition are unclear (2, 3, (5) (6) (7) (8) (9) (10) . Therefore, understanding this deregulation is fundamental in developing strategies that promote adipose lipogenesis, to increase lipid sequestration in adipocytes and prevent ectopic fat deposition during obesity.
Srebp-1 and Srebp-2 are transcription factors important for regulating the expression of genes involved in synthesis and uptake of cholesterol, FA, TG, and phospholipids (11) . These factors reside in the endoplasmic reticulum (ER) and upon demand for lipid synthesis are transported to the Golgi apparatus where they are cleaved, allowing the functional N-terminal fragment to translocate into the nucleus and regulate lipogenic gene expression (11) . Srebp transcription factors have distinctive specificities: Srebp-2 mainly controls expression of genes involved in the cholesterol biosynthetic pathway while Srebp-1 controls lipogenic gene expression; however, overlap in function has been reported (11, 12) . Srebp-1 is an important by guest, on August 15, 2017 www.jlr.org Downloaded from regulator of lipogenesis because it controls the expression of solute carrier family 2 (facilitated glucose transporter) member 4 (Slc2a4 or Glut4) (13) , ATP citrate lyase (Acly) (14) , acetylCoenzyme A carboxylase alpha (Acaca) (15) , fatty acid synthase (Fasn) (16, 17) , stearoylCoenzyme A desaturase 1 (Scd-1) (18), glycerol-3-phosphate acyltransferase (Gpat) (19) , and PPARγ (20, 21) . Srebp-1, in turn, is positively regulated by mechanistic target of rapamycin (mTORC1) (22) (23) (24) (25) and negatively regulated by AMPK (26) (27) (28) . Although the mechanism used by mTOR to promote the activity of Srebp-1 is not fully understood, increased PPARγ function in response to mTORC1 activation may contribute to increased Srebp-mediated adipose lipogenesis (22, (29) (30) (31) (32) (33) (34) .
Mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4) is a serine/threonine protein kinase related to S. cerevisiae Sterile 20 (Ste 20) protein kinases. Previous work has suggested that Map4k4 is a pro-inflammatory kinase that activates c-Jun NH 2 -terminal kinase (JNK) protein kinase (35) (36) (37) . This would be in keeping with a role for Map4k4 as a Ste20-like protein kinase, upstream of the terminal MAP kinases (38) (39) (40) . We identified Map4k4 in an RNAi screen as a protein kinase that regulates insulin-stimulated glucose transport in cultured adipocytes (41) . Map4k4 has also been reported to inhibit mTORC1, resulting in decreased PPARγ protein levels (29) . Since Map4k4 expression increases in adipose tissue in obese subjects while adipose lipogenesis decreases (42) , and Map4k4 negatively regulates mTOR (29), we aimed to test the role of Map4k4 in adipose lipogenesis and whether its actions require mTOR or the JNK protein kinase pathway. These studies extend our previous understanding of Map4k4 as a potential regulator of adipocyte lipid synthesis by demonstrating that Map4k4 suppresses lipogenesis in an mTOR-dependent and JNK-independent manner.
by guest, on August 15, 2017 www.jlr.org Downloaded from used for each transfection and empty vector was used to achieve equal amounts of DNA between conditions. Knockdown experiments in HEK 293T cells were achieved using Lipofectamine RNAi Max (Invitrogen), following the manufacturer's protocol.
RNA Isolation, Real Time PCR, Affymetrix Gene Chip Analysis-Total RNA was extracted from adipocytes using TriPure isolation reagent (Roche) following manufacturer's instructions.
cDNA was synthesized using iScript cDNA Synthesis Kit (BioRad) and quantitative RT-PCR was performed using iQ SybrGreen supermix and analyzed as previously described (46, 47) . 36B4 (Rplp0) and Hprt served as housekeeping internal controls.
For Affymetrix Gene Chip analysis, RNA was isolated from three independent experiments and hybridized to three different murine genome MOE430-2 microarrays. RNA quality was measured using the Agilent 2100 Bioanalyzer. Differentially expressed mRNAs were identified using a random-variance t-test. Sodium Acetate, 2mM sodium pyruvate) was added in all wells. 1 µM insulin was added to corresponding wells for 1.5 hr. Phospho-JNK and JNK, DYKDDDDDK Tag, HA, phospho-4EBP and total 4EBP, phospho-S6 and total S6 antibodies were purchased from Cell Signaling.
Phospho-cJun and cJun antibodies were purchased from Santa Cruz. Actin and Flag M2 antibodies were purchased from Sigma and Map4k4 antibody was purchased from Bethyl (#A301-503A).
Srebp Immunoblotting-Srebp-1 antibody was purchased from Millipore (Clone 2121) and Srebp-2 was purchased from Cayman Chemical (#10007663). A minimum of 30µg of protein lysates (2% SDS, 150 mM NaCl and 5mM EDTA) was resolved by SDS-PAGE (8%) and electrotransferred to nitrocellulose membranes. Membranes were incubated with indicated antibodies overnight at 4°C (1:1000). Blots were washed with TBST (0.1% Tween 20 in TrisBuffered saline), incubated with horseradish peroxidase anti-mouse (for Srebp-1) or anti-rabbit secondary antibody (for Srebp-2) (1hr) and visualized using enhanced chemiluminescent substrate kit (Perkin Elmer). It is important to note that a non-specific band is recognized by 
RESULTS

Map4k4 depletion enhances metabolic gene expression
We have previously shown that Map4k4 depletion enhances PPARγ protein expression and TG accumulation in cultured adipocytes (29, 41) . To further investigate the effects of (Fig. 1A) . We further validated the mRNA expression of several metabolic genes upon Map4k4 depletion in cultured adipocytes (Fig. 1B) .
These analyses suggest that Map4k4 suppresses lipid metabolism-related processes in cultured adipocytes.
Map4k4 functions as a repressor of triglyceride synthesis in cultured adipocytes
To further assess the role of Map4k4 as a negative regulator of TG synthesis in adipocytes, we depleted Map4k4 in mature 3T3-L1 adipocytes using siRNA or elicited increased Map4k4 expression using adenovirus vectors, and measured the conversion of 14 C-glucose into neutral lipids. Consistent with the hypothesis that Map4k4 inhibits lipid synthesis, Map4k4 knockdown resulted in approximately 50% increased incorporation of the 14 C-radiolabel into neutral lipids compared to the scrambled control ( Fig. 2A) . Conversely, Map4k4 overexpression significantly reduced 14 C-radiolabel incorporation into TG by ~29% compared to the adenovirus HA-control (Ad: HA-control) ( Fig. 2A) . To determine whether Map4k4 was suppressing glycerol-3-phosphate (G-3-P) formation or de novo lipogenesis, we measured 14 C-radiolabel incorporation into both FA of TG (Fig. 2B ) and glyceride-glycerol (Fig 2C) . We determined that
Map4k4 inhibited both glyceride-glycerol formation and de novo lipid synthesis in mature adipocytes as seen by increased incorporation of the radiolabel into both molecules upon Map4k4 depletion and decreased incorporation upon Map4k4 overexpression ( Fig. 2B-C) . We also confirmed that these observed changes in neutral lipid synthesis and de novo lipogenesis reflect changes in TG and FA, respectively, by TLC analysis (data not shown).
We have previously reported that Map4k4 silencing increases Glut4 expression and glucose uptake (41), possibly providing the substrate for both glyceride-glycerol and fatty acid synthesis. To distinguish the contribution of Map4k4 regulation to these processes, we used either control or Map4k4 siRNA-transfected adipocytes and measured 14 C-acetate incorporation into TG, a measure of de novo lipogenesis, as the radiolabel bypasses glucose transport and metabolism to provide substrate for FA synthesis. Consistent with the results from Fig. 2A -B, Map4k4 depletion significantly increased 14 C-acetate incorporation into TG and its constituent FA ( Fig. 2D-E) . Representative protein immunoblots confirmed Map4k4 knockdown or overexpression at the protein level (Fig. 2F) . These results indicate that Map4k4 is a negative regulator of glucose flux, de novo FA synthesis and TG synthesis in cultured adipocytes. Map4k4 depletion significantly increased 14 C-acetate incorporation into TG (Fig. 3A-B) .
Surprisingly, depletion of the two major isoforms of JNK, JNK1 and JNK2, significantly reduced TG synthesis by 56%, opposite to the Map4k4 knockdown-induced increase in TG synthesis (Fig. 3A-B) . Furthermore, 14 C-acetate incorporation into FA, a measure of de novo lipogenesis, was significantly increased upon Map4k4 silencing (~47%) and decreased upon JNK depletion (~20%) (Fig. 3C) . Efficient Map4k4 and JNK protein depletion was confirmed by protein immunoblots (Fig. 3D ). These data demonstrate that while Map4k4 downregulates lipogenesis, JNK1 and JNK2 are required for this process. We next examined whether JNK and Map4k4 depletion affected lipogenic gene expression in a dissimilar fashion using RT-qPCR (Fig. 3C ).
Gene expression was normalized to 36B4, and the gene expression in Map4k4 or JNK depleted cells was compared to that in scrambled siRNA-treated control cells. Comparison of the relative mRNA expression of Srebp-1, ChREBP, Fasn, Scd-1, Pepck, and Glut4 shows that while Map4k4 depletion increased the mRNA expression of these enzymes, JNK depletion decreased the mRNA expression of these genes (Fig. 3D) . These results indicate that Map4k4 is a repressor of adipose lipogenesis while JNK is an unexpected positive regulator of this metabolic process.
Thus, Map4k4 does not repress lipogenesis in a JNK-dependent manner.
Map4k4 does not activate the JNK signaling pathway in adipocytes
These divergent effects of Map4k4 and JNK were unexpected in light of previous reports that Map4k4 functions as an upstream activator of JNK in various cell models (35) (36) (37) . To further investigate whether increased Map4k4 expression and activity would be sufficient to increase endogenous JNK signaling in adipocytes, we used adenoviral-mediated Map4k4 overexpression followed by stimulation with tumor necrosis factor alpha (TNFα), a potent JNK activator ( fos, and JunD -in response to TNFα (Fig. 4D) . As expected and consistent with previous results (50), JNK depletion attenuated the maximal response of these AP-1 transcriptional factors in response to TNFα (Fig. 4D) . These results indicate that Map4k4 is neither sufficient nor required to induce JNK activation in adipocytes. Furthermore, using gain-and loss-of-function approaches in HEK 293T cells, we show that co-transfection of both Map4k4 and JNK results in increased JNK activity (Sup . Fig. 4A) ; however, depletion of endogenous Map4k4 did not diminish JNK activity (Sup. Fig. 4B ), suggesting that Map4k4 is not an endogenous modulator of JNK activity. These results support the notion that endogenous Map4k4 is not required for optimal endogenous JNK activation in adipocytes or HEK 293T cells, but that artificially high levels of exogenously expressed Map4k4 can induce JNK activation when JNK is also overexpressed.
Map4k4 inhibits lipid synthesis in an mTOR-dependent manner
We have previously demonstrated that Map4k4 impairs mTORC1 signaling (29) and since mTORC1 signaling enhances lipid synthesis (22, 24, 34, 51) , we tested whether Map4k4 required mTORC1 to inhibit lipid synthesis. We depleted Map4k4 using siRNA and treated the cells with rapamycin, an mTORC1 inhibitor, to repress mTORC1 signaling. Consistent with previous reports, Map4k4 depletion enhanced mTORC1 signaling as demonstrated by increased ribosomal protein S6 (S6) and eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1/Eif4ebp1) protein phosphorylation (29) (Fig. 5A) . Interestingly, Map4k4 depletion also increased Srebp-1 protein levels, an important lipogenic transcription factor (Fig. 5A ).
Rapamycin treatment inhibited mTORC1 signaling, as evidenced by a lack of S6 and 4E-BP1 protein phosphorylation, and abolished the increase in Srebp-1 protein expression due to Map4k4 silencing (Fig. 5A ). Rapamycin treatment also diminished the Map4k4 silencing-induced increase in 14 C-glucose incorporation into TG (Fig. 5B) and FA (Fig. 5C ). These results indicate that mTORC1 function is necessary for Srebp-1 expression and optimal lipid synthesis in cultured adipocytes and support the notion that Map4k4 represses the mTORC1/Srebp pathway to decrease adipose lipogenesis.
Map4k4 depletion requires Srebp expression to enhance lipid synthesis
We demonstrated that Map4k4 depletion enhances mTORC1 signaling and increases Srebp-1 protein expression (Fig. 5A) . As an alternative approach to assess the effect of impaired Map4k4 function, we used a kinase-inactive mutant of Map4k4 (AdMap4k4 D152N) (52) , previously shown to function as a dominant-negative inhibitor (53) . Consistent with knockdown experiments (Fig. 5A ), Map4k4 D152N overexpression resulted in a significant increase of Srebp-1 protein levels (Sup. Fig. 2 ). To determine whether Map4k4 required this increase in (Fig. 6A) . Furthermore, Map4k4 silencing significantly increased the mRNA expression of known Srebp-1 lipogenic target genes Acaca (~73%), Scd-1 (~78%), and Fasn (~23%) (15, 17, 18 ) and depletion of Srebp severely blunted the enhanced expression of these genes in response to Map4k4 silencing (Fig. 6B) . Importantly, Map4k4 depletion significantly increased 14 Cglucose conversion into both TG (Fig. 6C) and FA (Fig. 6D) , as demonstrated in previous figures, and depletion of both Srebp proteins significantly reduced the increase of radiolabel incorporation into TG and FA in response to Map4k4 silencing (Fig. 6C-D) . These results indicate that Srebp proteins are necessary for optimal adipose lipogenesis and are also required for the Map4k4 knockdown-induced enhancement of lipid synthesis.
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Map4k4 is a positive regulator of AMPK.
Map4k4 has been implicated as a possible positive regulator of AMPK phosphorylation (54) , and AMPK is a negative regulator of mTOR, suggesting a plausible mechanism by which Map4k4 may regulate mTOR and inhibit lipogenesis. We verified that Map4k4 regulates AMPK phosphorylation and activity in adipocytes by treating Map4k4-depleted adipocytes with oligomycin, an inhibitor of ATP synthase and potent activator of AMPK. As expected, treatment of adipocytes with oligomycin (500 nM for 30 minutes) increased AMPK phosphorylation. This response was significantly blunted in Map4k4-depleted adipocytes ( Fig. 7A-B) . Furthermore, decreased AMPK activation results in increased mTOR signaling, as assessed by decreased
Raptor phosphorylation (Ser792) and increased lipogenesis, as assessed by ACC phosphorylation (Ser79) (Fig. 7A) . On the other hand, increased Map4k4 expression and activity results in increased AMPK signaling as seen in Map4k4-overexpressing adipocytes treated with oligomycin (500 nM for 30 minutes) (Fig. 7C-D) . These results suggest Map4k4 is necessary for optimal AMPK activation and provide insight into the mechanism by which Map4k4 inhibits mTOR and lipid synthesis in mature adipocytes.
DISCUSSION
Here we show that adipose Map4k4 represses glucose incorporation into FA and TG, at least in part via upregulation of AMPK signaling which results in downregulation of mTOR function and Srebp-1 expression. We found that Map4k4 depletion enhances the conversion of These results extend our previous findings that Map4k4 represses mTOR signaling in adipocytes (29) and shed insight into the mechanism by which Map4k4 represses lipid synthesis. 
